Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate

被引:544
作者
Sanna, MG
Liao, JY
Jo, EJ
Alfonso, C
Ahn, MY
Peterson, MS
Webb, B
Lefebvre, S
Chun, J
Gray, N
Rosen, H
机构
[1] Scripps Res Inst, Ctr Mass Spectrometry, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[4] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA
关键词
D O I
10.1074/jbc.M311743200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingosine 1-phosphate (S1P) influences heart rate, coronary artery caliber, endothelial integrity, and lymphocyte recirculation through five related high affinity G-protein-coupled receptors. Inhibition of lymphocyte recirculation by non-selective S1P receptor agonists produces clinical immunosuppression preventing transplant rejection but is associated with transient bradycardia. Understanding the contribution of individual receptors has been limited by the embryonic lethality of the S1P(1) knock-out and the unavailability of selective agonists or antagonists. A potent, S1P(1)-receptor selective agonist structurally unrelated to S1P was found to activate multiple signals triggered by S1P, including guanosine 5'-3-O-( thio) triphosphate binding, calcium flux, Akt and ERK1/2 phosphorylation, and stimulation of migration of S1P(1)- but not S1P(3)-expressing cells in vitro. The agonist also alters lymphocyte trafficking in vivo. Use of selective agonism together with deletant mice lacking S1P(3) receptor reveals that agonism of S1P(1) receptor alone is sufficient to control lymphocyte recirculation. Moreover, S1P(1) receptor agonist plasma levels are causally associated with induction and maintenance of lymphopenia. S1P(3), and not S1P(1), is directly implicated in sinus bradycardia. The sustained bradycardia induced by S1P receptor nonselective immunosuppressive agonists in wild-type mice is abolished in S1P(3)(-/-) mice, whereas S1P(1)-selective agonist does not produce bradycardia. Separation of receptor subtype usage for control of lymphocyte recirculation and heart rate may allow the identification of selective immunosuppressive S1P(1) receptor agonists with an enhanced therapeutic window. S1P(1)- selective agonists will be of broad utility in understanding cell functions in vitro, and vascular physiology in vivo, and the success of the chemical approach for S1P(1) suggests that selective tools for the resolution of function across this broad lipid receptor family are now possible.
引用
收藏
页码:13839 / 13848
页数:10
相关论文
共 44 条
[1]   G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation [J].
Allende, ML ;
Yamashita, T ;
Proia, RL .
BLOOD, 2003, 102 (10) :3665-3667
[2]   Sphingosine-1-phosphate receptors and the development of the vascular system [J].
Allende, ML ;
Proia, RL .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1582 (1-3) :222-227
[3]   The immune modulator FTY720 targets sphingosine 1-phosphate receptors [J].
Brinkmann, V ;
Davis, MD ;
Heise, CE ;
Albert, R ;
Cottens, S ;
Hof, R ;
Bruns, C ;
Prieschl, E ;
Baumruker, T ;
Hiestand, P ;
Foster, CA ;
Zollinger, M ;
Lynch, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21453-21457
[4]   FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity [J].
Brinkmann, V ;
Lynch, KR .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (05) :569-575
[5]   FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation [J].
Brinkmann, V ;
Pinschewer, D ;
Chiba, K ;
Feng, LL .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (02) :49-52
[6]   FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression [J].
Brinkmann, V ;
Chen, S ;
Feng, L ;
Pinschewer, D ;
Nikolova, Z ;
Hof, R .
TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) :530-531
[7]   FTY720: Altered lymphocyte traffic results in allograft protection. [J].
Brinkmann, V ;
Pinschewer, DD ;
Feng, L ;
Chen, S .
TRANSPLANTATION, 2001, 72 (05) :764-769
[8]   Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients [J].
Budde, K ;
Schmouder, RL ;
Nashan, B ;
Brunkhorst, R ;
Lücker, PW ;
Mayer, T ;
Brookman, L ;
Nedelman, J ;
Skerjanec, A ;
Böhler, T ;
Neumayer, HH .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (07) :846-854
[9]   Sphingosine 1-phosphate and control of vascular tone [J].
Dantas, APV ;
Igarashi, J ;
Michel, T .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (06) :H2045-H2052
[10]  
DOHERTY G, 2003, Patent No. 03061567